½ÃÀ庸°í¼­
»óǰÄÚµå
1572481

ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ±âȸ, ¼ºÀå µ¿ÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)

Clinical Perinatal Software Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀÓ»ó ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2023³â 2¾ï 7,720¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 9.9% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸î °¡Áö ÁÖ¿ä Æ®·»µå°¡ ½ÃÀåÀÇ ¿ªµ¿ÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)À» ÁÖ»ê±â ¼ÒÇÁÆ®¿þ¾î ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ¸é ¿¹Ãø ºÐ¼®°ú À§Çè Æò°¡¸¦ °­È­ÇÏ¿© »ê¸ð¿Í žÆÀÇ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, È®À强, Á¢±Ù¼º ¹× ½Ç½Ã°£ µ¥ÀÌÅÍ °øÀ¯¸¦ Á¦°øÇϴ Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÁÖ»ê±â °øµ¿ Áø·á¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ¿ø°Ý ¸ð´ÏÅ͸µ°ú ¿ø°Ý ÀǷḦ Áö¿øÇÏ¿© ¿ø°ÝÁö¿¡ ÀÖ´Â ÀÓ»êºÎ¸¦ Áö¼ÓÀûÀ¸·Î µ¹º¼ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

Á¦Ç° À¯Çü¿¡ µû¶ó ÅëÇÕ ¼Ö·ç¼Ç°ú µ¶¸³Çü ¼Ö·ç¼ÇÀ¸·Î ±¸ºÐµÇ¸ç, 2023³â¿¡´Â ÅëÇÕ ¼Ö·ç¼Ç ºÎ¹®ÀÌ 1¾ï 6,800¸¸ ´Þ·¯ÀÇ ¸ÅÃâ·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®Àº EHR, û±¸ ½Ã½ºÅÛ, PACS, AI, µ¥ÀÌÅÍ ºÐ¼® µî ¿øÈ°ÇÑ ¿öÅ©Ç÷οì ÅëÇÕ°ú ±â¼ú ¹ßÀü¿¡ ´ëÇÑ ¼ö¿ä·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀÇ °­È­´Â º¸´Ù Á¤È®ÇÑ ¿¹Ãø°ú ¸ÂÃãÇü Ä¡·á °èȹÀ¸·Î À̾îÁ® »êºÎÀΰú Áø·á¿¡¼­ äÅÃÀ» Áõ°¡½Ãų °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù Pediatrix Medical GroupÀº Ŭ¶ó¿ìµå ±â¹Ý AI ±â¹Ý »êÀü °ü¸® ¼­ºñ½ºÀÎ Sonio¸¦ äÅÃÇÏ¿© ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí ÀÓ»ó °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù.

¹èÄ¡ ¸ðµåº°·Î´Â ¿ÂÇÁ·¹¹Ì½º ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀÌ ÀÖ½À´Ï´Ù. ¿ÂÇÁ·¹¹Ì½ºÇü ¼Ö·ç¼ÇÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È 9.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎÁ¤º¸ º¸È£¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ±â°üµéÀÌ HIPAA¿Í °°Àº ¾ö°ÝÇÑ ±ÔÁ¦¸¦ ÃæÁ·Çϱâ À§ÇØ ¹Î°¨ÇÑ È¯ÀÚ µ¥ÀÌÅ͸¦ Á÷Á¢ °ü¸®ÇÏ´Â °ÍÀ» ¼±È£Çϱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ¿ÂÇÁ·¹¹Ì½º´Â »ç¿ëÀÚ Á¤Àǰ¡ °¡´ÉÇÏ°í ±âÁ¸ º´¿ø ½Ã½ºÅÛ°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀÌ °¡´ÉÇÏ´Ù´Â ÀåÁ¡µµ ÀÖ½À´Ï´Ù.

2023³â ºÏ¹Ì ÁÖ»ê±â ÀÓ»ó ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¸ÅÃâÀº 1¾ï 3,700¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, °ßÁ¶ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. Àß Á¤ºñµÈ ÀÇ·á ½Ã½ºÅÛ°ú ³ôÀº ÀÇ·áºñ µîÀÇ ¿äÀÎÀÌ ÀÌ Áö¿ª ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ¸ÞµðÄɾî-¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ(CMS)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¹Ì±¹ÀÇ ÀÇ·áºñ ÁöÃâÀº 2031³â±îÁö 7Á¶ 2,000¾ï ´Þ·¯¸¦ ³Ñ¾î GDPÀÇ 20.0%¿¡ À°¹ÚÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ÁÖ»ê±â Ãâ»êÀ²Àº »ê¸ðÀÇ ³ªÀÌ¿Í °Ç°­ »óÅ µî ´Ù¾çÇÑ ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • ±â¼úÀû Àü¸Á
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • °¸ ºÐ¼®
  • ÀΰøÁö´É : ÁÖ»ê±â ÀÓ»óÀÇÀ» À§ÇÑ ÀÔ¹®¼­

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç° À¯Çüº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÅëÇÕÇü
  • ½ºÅĵå¾ó·Ð

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Àü°³ ¸ðµåº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¿ÂÇÁ·¹¹Ì½º
  • Ŭ¶ó¿ìµå ±â¹Ý

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÅÂ¾Æ ¸ð´ÏÅÍ µ¥ÀÌÅÍ ¼­ºñ½º
  • ¿öÅ©ÇÃ·Î¿ì °ü¸®
  • ȯÀÚ ´ÙÅ¥¸àÅ×À̼Ç

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • »ê°ú Ŭ¸®´Ð

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ±â¾÷ °³¿ä

  • AS Software LLC
  • Clinical Computer Systems Inc
  • GE HealthCare
  • Glen Med Solutions
  • Huntleigh Healthcare Limited
  • K2 Medical Systems Ltd
  • Koninklijke Philips NV
  • MCKESSON CORPORATION
  • PeriGen Inc.
  • Revvity
  • Sonio SAS
  • Trium Analysis Online GmbH
LSH 24.10.28

The Global Clinical Perinatal Software Market was valued at USD 277.2 million in 2023 and is projected to grow at a CAGR of 9.9% from 2024-2032. Several key trends are driving the market's dynamic growth. The integration of artificial intelligence (AI) and machine learning (ML) into perinatal software systems enhances predictive analytics and risk assessments, improving outcomes for mothers and fetuses. Additionally, the adoption of cloud-based solutions is rising, offering scalability, accessibility, and real-time data sharing, crucial for collaborative care during the perinatal phase. This shift supports remote monitoring and telehealth, enabling continuous care for expectant mothers in remote regions.

The overall clinical perinatal software industry is classified based on the product type, deployment mode, application, end-use, and region.

The market is segmented by product type into integrated and standalone solutions. In 2023, the integrated segment led the market with USD 168.0 million in revenue. This segment is expected to expand rapidly due to the demand for seamless workflow integration and technological advancements, including EHR, billing systems, PACS, AI, and data analytics. Enhanced software capabilities lead to more accurate predictions and tailored treatment plans, increasing adoption in maternity care. For instance, in January 2024, Pediatrix Medical Group adopted Sonio, a cloud-based, AI-driven prenatal care service, streamlining workflows and improving clinical outcomes.

By deployment mode, the market features on-premises and cloud-based solutions. The on-premises segment leads the market and is projected to grow at a CAGR of 9.3% during the forecast period. This preference is driven by heightened data security and privacy concerns, with healthcare institutions favoring direct control over sensitive patient data to meet stringent regulations like HIPAA. The on-premises model also offers enhanced customization and seamless integration with existing hospital systems.

In 2023, North America accounted for USD 103.7 million in revenue from the clinical perinatal software market, with robust growth projections. Factors such as a well-structured healthcare system and high healthcare spending drive this regional market's expansion. Data from the Centers for Medicare and Medicaid Services (CMS) suggests that U.S. healthcare spending could surpass USD 7.2 trillion by 2031, nearing 20.0% of the GDP. Perinatal birth rates in the region are influenced by various factors, including maternal age and health conditions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising number of natal mortality and preterm births
      • 3.2.1.2 Increasing adoption of artificial intelligence and data analytics in perinatal monitoring
      • 3.2.1.3 Growing government initiatives and awareness regarding fetal care
      • 3.2.1.4 Increasing healthcare expenditure
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Budget constraints and the need for extensive training
      • 3.2.2.2 Privacy and security concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Future market trends
  • 3.6 Technological landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Artificial Intelligence: A primer for perinatal clinicians

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Integrated
  • 5.3 Standalone

Chapter 6 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 On-premises
  • 6.3 Cloud-based

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Fetal monitor data services
  • 7.3 Workflow management
  • 7.4 Patient documentation

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Maternity clinics

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AS Software LLC
  • 10.2 Clinical Computer Systems Inc
  • 10.3 GE HealthCare
  • 10.4 Glen Med Solutions
  • 10.5 Huntleigh Healthcare Limited
  • 10.6 K2 Medical Systems Ltd
  • 10.7 Koninklijke Philips NV
  • 10.8 MCKESSON CORPORATION
  • 10.9 PeriGen Inc.
  • 10.10 Revvity
  • 10.11 Sonio SAS
  • 10.12 Trium Analysis Online GmbH
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦